Announcements Trials
Browse Landscape

Status

Completed 2Withdrawn 1No longer available 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

regorafenib 3zanidatamab 1peginterferon alfa-2a 1pegilodecakin 1onvansertib 1omburtamab I-131 1guselkumab 1derazantinib 1avapritinib 1Tenofovir 1Melphalan 1Imatinib Mesylate 1IMM-101 1IFL protocol 1HMPL-013 1Everolimus 1Brachytherapy 1Bevacizumab 1AM0010 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × IMM-101 × Gastrointestinal × Clear all
NCT04137822 2020-08-14

Expanded Access Program Using IMM-101 for Patients With Advanced Pancreatic Cancer

Impatients N.V. trading as myTomorrows

No longer available
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡